CXAI
CXApp Inc.
There isn't enough reported data to score CXAI yet.
NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
CXAI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Unavailable | |
| Strong |
CXAI's revenue and balance sheet are currently strong, but its profitability is under pressure. There isn't enough data to rate its cash flow.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CXAI PE Valuation
CXAI has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
CXAI Forward outlook
There aren't enough analyst estimates for CXAI to show an outlook.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CXAI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$21.35 | +$9.65 |
| Q2 2026 | -$26.50 | +$14.00 |
| Q1 2026 | -$29.50 | +$20.00 |
| Q4 2025 | -$29.00 | +$33.50 |
| Q3 2025 | -$31.00 | +$135.50 |
| Q2 2025 | -$40.50 | +$103.50 |
| Q1 2025 | -$49.50 | +$120.00 |
| Q4 2024 | -$62.50 | +$105.50 |
CXAI is still losing money, but far less than before: $21.35 per share over the past year, against $169.50 at its worst in early 2024.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CXAI on earnings quality, reporting a profit while its opponent remains loss making.
CXAI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3M | +170% |
| Q2 2026 | $1.7M | +39% |
| Q1 2026 | $950K | -22% |
| Q4 2025 | $1M | -38% |
| Q3 2025 | $1.1M | -41% |
| Q2 2025 | $1.2M | -31% |
| Q1 2025 | $1.2M | -33% |
| Q4 2024 | $1.7M | -3.4% |
CXAI's revenue is growing: $3M last quarter, up 170% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -105% | +238 points |
| Q2 2026 | -243% | +93 points |
| Q1 2026 | -434% | -128 points |
| Q4 2025 | -577% | -386 points |
| Q3 2025 | -343% | -168 points |
| Q2 2025 | -336% | -130 points |
| Q1 2025 | -306% | -109 points |
| Q4 2024 | -191% | +2125 points |
CXAI's operating margin was −105% last quarter, up 238 points from the same quarter a year ago, near the top of its range since 2023.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CXAI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CXAI on profitability, with a higher operating margin.
CXAI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.7M | +$99K |
| Q4 2025 | -$3.6M | -$937K |
| Q3 2025 | -$2.8M | -$691K |
| Q2 2025 | -$3M | -$1.1M |
| Q1 2025 | -$984K | -$316K |
| Q4 2024 | -$2.7M | +$1.1M |
| Q3 2024 | -$2.1M | +$287K |
| Q2 2024 | -$1.9M | +$4.7M |
NVDA has the stronger cash trend. Its trailing FCF is up 290% versus its history, compared with CXAI at down 35%.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA's free cash flow has been positive every quarter for six years: $127B over the past year, up 76% from the year before.
CXAI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.9% | +230K shares |
| 1 year | +348% | +2M shares |
| 3 years | +1058% | +2.3M shares |
| 5 years | +2040% | +2.4M shares |
CXAI has 3M diluted shares, up 348% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over CXAI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CXAI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2021 | -0.1x | Net Cash |
CXAI has more cash than debt.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CXAI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.0 | Oversold |
| Stochastic | 2.2 | Oversold |
CXAI's weekly RSI is 30 (oversold) and its Stochastic is 2 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CXAI PE vs Technology Sector
| Metric | CXAI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CXAI has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
CXAI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.85 | 26% below |
| 20 week MA | $3.95 | 65% below |
| 50 week MA | $8.80 | 84% below |
| 100 week MA | $31.3 | 96% below |
| 200 week MA | $116.3 | 99% below |
CXAI is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over CXAI on trend strength, trading above more of its moving averages.
CXAI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $511.5 | $498.0 | -2.6% |
| 2022 | $498.0 | $497.5 | -0.1% |
| 2023 | $497.5 | $64.5 | -87% |
| 2024 | $64.5 | $103.5 | +60% |
| 2025 | $103.5 | $16.5 | -84% |
| 2026 YTD | $16.5 | $1.37 | -92% |
CXAI has finished lower in four of the last five years. It's down 92% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over CXAI on returns for 2026, with the stronger performance.